Search Results - "Berton-Rigaud, Dominique"

Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer.

Authors: King, Madeleine T. Stockler, Martin R. O’Connell, Rachel L. et al.

Source: Quality of Life Research. Jan2018, Vol. 27 Issue 1, p59-74. 16p.

Subjects: Ovarian cancer treatment, Ovarian cancer diagnosis, Cancer chemotherapy, Health surveys, Palliative treatment, Mental health, Quality of life, Cancer relapse, Comparative studies, Health status indicators, Longitudinal method, Research methodology, Medical cooperation, Ovarian tumors, Questionnaires, Research, Research evaluation, Research funding, Evaluation research

Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) – Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS).

Authors: Roncolato, Felicia T. Berton-Rigaud, Dominique O'Connell, Rachel et al.

Source: Gynecologic Oncology. Jan2018, Vol. 148 Issue 1, p36-41. 6p.

The CD47/TSP-1 axis: a promising avenue for ovarian cancer treatment and biomarker research.

Authors: Moniot, Aurélie Schneider, Christophe Chardin, Laure et al.

Source: Molecular Cancer. 8/14/2024, Vol. 23 Issue 1, p1-17. 17p.

Early Death in Advanced Ovarian Cancer in Older Adults.

Authors: Lefur, Eloise Berton‐Rigaud, Dominique Boureau, Anne S. et al.

Source: Journal of the American Geriatrics Society. May2014, Vol. 62 Issue 5, p976-977. 2p. 1 Chart.

Subjects: Geriatric assessment, Chi-squared test, Ovarian tumors, T-test (Statistics), Logistic regression analysis, Cross-sectional method, Retrospective studies, Geriatric Depression Scale, Data analysis software, Descriptive statistics, Old age

Surgical Implications of Advanced Low-Grade Serous Ovarian Cancer: Analysis of the Database of the Tumeurs Malignes Rares Gynécologiques Network.

Authors: Bonsang-Kitzis, Hélène Panchbhaya, Nabilah Bats, Anne-Sophie et al.

Source: Cancers. May2022, Vol. 14 Issue 9, pN.PAG-N.PAG. 13p.

"Chronic fatigue, quality of life and long-term side-effects of chemotherapy in patients treated for non-epithelial ovarian cancer: national case-control protocol study of the GINECO-Vivrovaire rare tumors INCa French network for rare malignant ovarian tumors".

Authors: Gernier, François Ahmed-Lecheheb, Djihane Pautier, Patricia et al.

Source: BMC Cancer. 10/26/2021, Vol. 21 Issue 1, p1-12. 12p.

BRCA1/2 mutations associated with progression-free survival in ovarian cancer patients in the AGO-OVAR 16 study.

Authors: Harter, Philipp Johnson, Toby Berton-Rigaud, Dominique et al.

Source: Gynecologic Oncology. Mar2016, Vol. 140 Issue 3, p443-449. 7p.

Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers.

Authors: Cottu, Paul H. Bonneterre, Jacques Varga, Andrea et al.

Source: PLoS ONE. 10/10/2018, Vol. 13 Issue 10, p1-16. 16p.

NY-ESO-1-Specific Circulating CD4⁺ T Cells in Ovarian Cancer Patients Are Prevalently TH1 Type Cells Undetectable in the CD25⁺ FOXP3⁺ Treg Compartment.

Authors: Redjimi, Nassima Duperrier-Amouriaux, Karine Raimbaud, Isabelle et al.

Source: PLoS ONE. 2011, Vol. 6 Issue 7, p1-9. 9p.

Comparative analysis of predictive values of the kinetics of 11 circulating miRNAs and of CA125 in ovarian cancer during first line treatment (a GINECO study).

Authors: Robelin, Patrick Tod, Michel Colomban, Olivier et al.

Source: Gynecologic Oncology. Oct2020, Vol. 159 Issue 1, p256-263. 8p.

Pembrolizumab in patients with programmed death ligand 1–positive advanced ovarian cancer: Analysis of KEYNOTE-028.

Authors: Varga, Andrea Piha-Paul, Sarina Ott, Patrick A. et al.

Source: Gynecologic Oncology. Feb2019, Vol. 152 Issue 2, p243-250. 8p.

Non-pegylated liposomal doxorubicin (NPLD, Myocet®) + carboplatin in patients with platinum sensitive ovarian cancers: A ARCAGY-GINECO phase IB-II trial.

Authors: Romeo, Clémence Joly, Florence Ray-Coquard, Isabelle et al.

Source: Gynecologic Oncology. Jan2019, Vol. 152 Issue 1, p68-75. 8p.

Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial.

Authors: Oza, Amit M Matulonis, Ursula A Malander, Susanne et al.

Source: Lancet Oncology. Aug2018, Vol. 19 Issue 8, p1117-1125. 9p.

Prognostic impact of time to first recurrence in low-grade serous ovarian carcinoma: A multicentric retrospective study from the French TMRG network.

Authors: Montassier T Laas E Hotton J et al.

Source: Gynecologic oncology [Gynecol Oncol] 2026 Jun 26; Vol. 211, pp. 59-66. Date of Electronic Publication: 2026 Jun 26.

Publication Type: Journal Article

Journal Info: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

Long-term quality of life in non-epithelial ovarian cancer survivors: TMRG-GINECO-Vivrovaire rare tumors case-control study.

Authors: Dubot C Ray-Coquard I Lequesne J et al.

Source: BMC medicine [BMC Med] 2025 Dec 12; Vol. 24 (1), pp. 34. Date of Electronic Publication: 2025 Dec 12.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015 (Electronic) Linking ISSN: 17417015 NLM ISO Abbreviation: BMC Med Subsets: MEDLINE

Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant Chemotherapy.

Authors: Yaniz-Galende E Zeng Q Bejar-Grau JF et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jul 01; Vol. 30 (13), pp. 2790-2800.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas.

Authors: Sertier AS Ferrari A Pommier RM et al.

Source: Cancer research communications [Cancer Res Commun] 2023 May 10; Vol. 3 (5), pp. 830-841. Date of Electronic Publication: 2023 May 10 (Print Publication: 2023).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: eCollection Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE

Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study.

Authors: Roncolato FT Joly F O'Connell R et al.

Corporate Authors: Roncolato FT Joly F O'Connell R et al.

Source: The oncologist [Oncologist] 2017 Sep; Vol. 22 (9), pp. 1117-1124. Date of Electronic Publication: 2017 Jun 08.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Hormonoresistance in advanced breast cancer: a new revolution in endocrine therapy.

Authors: Augereau P Patsouris A Bourbouloux E et al.

Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2017 May; Vol. 9 (5), pp. 335-346. Date of Electronic Publication: 2017 Mar 14.

Publication Type: Journal Article; Review

Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

Survival Benefit of Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer: A Multi-institutional Case Control Study.

Authors: Le Brun, Jean-François Campion, Loic Berton-Rigaud, Dominique et al.

Source: Annals of surgical oncology Oct2014; Vol. 21 (10).

Journal Info: Publisher: Springer Nature ISSN: 1068-9265